| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 26, 2006
Accepted on September 25, 2006
From AP-HP, Hôpital Broussais (G.C., A.S., M.D.P., J.G.), Centre de Médecine Préventive Cardiovasculaire, Paris, France; Université René Descartes (G.C., A.S., M.D.P., J.G.), Paris, France; Unité INSERM U770 (B.H., J.M.F.), Hôpital Bicêtre, Le Kremlin Bicêtre; Institut d’Hématologie et d’Immunologie, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France; Unité INSERM U689 & Institut Fédératif de Recherche Circulation (A.T.), Paris, France.
* To whom correspondence should be addressed. E-mail: alain.simon{at}brs.aphp.fr.
Objective--To clarify circulating microparticles (MP) relationships with preclinical atherosclerosis.
Methods and Results--In 216 subjects without cardiovascular disease, we assessed: (1) annexin V-positive, platelet-derived, endothelium-derived and leukocyte-derived circulating MP by capture on annexin V, anti-GPIb, anti-CD105, and anti-CD11a antibody-coated wells, respectively; (2) Framingham risk, metabolic syndrome, and low-grade inflammation by risk factors measurement including hsCRP; and (3) subclinical atherosclerosis by ultrasound examination of carotid, abdominal aorta, and femoral arteries. Number of sites with plaque ranged from 0 to 3 and plaque burden was classified into 0 to 1 or 2 to 3 sites disease. Leukocyte-derived MP level was higher in the presence than in the absence of moderate to high Framingham risk (P<0.05), metabolic syndrome (P<0.01), high C-reactive protein (CRP) (P<0.05), or 2- to 3-site disease (P<0.01), and correlated positively with number of metabolic syndrome components (P<0.001), tertiles of fibrinogen (P<0.001), and number of diseased sites (P<0.01). In multivariate analysis, 2- to 3-site disease was independently associated with leukocyte-derived MP level (P<0.05), Framingham risk (P<0.001), and metabolic syndrome (P<0.01). None of the other MP types correlated with risk markers or atherosclerosis.
Conclusions--Leukocyte-derived MP, identified by affinity for CD11a, are increased in subjects with ultrasound evidence of subclinical atherosclerosis, unveiling new directions for atherosclerosis research.
This article has been cited by other articles:
![]() |
J. I. Zwicker, H. A. Liebman, D. Neuberg, R. Lacroix, K. A. Bauer, B. C. Furie, and B. Furie Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy Clin. Cancer Res., November 15, 2009; 15(22): 6830 - 6840. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ayers, B. Ferry, S. Craig, D. Nicoll, J. R. Stradling, and M. Kohler Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea Eur. Respir. J., March 1, 2009; 33(3): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Morel, F. Toti, N. Morel, and J.-M. Freyssinet Microparticles in endothelial cell and vascular homeostasis: are they really noxious? Haematologica, March 1, 2009; 94(3): 313 - 317. [Full Text] [PDF] |
||||
![]() |
G. Pasterkamp and D. de Kleijn Microparticles, Debris That Hurts J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1312 - 1313. [Full Text] [PDF] |
||||
![]() |
A. Agouni, A. H. Lagrue-Lak-Hal, P. H. Ducluzeau, H. A. Mostefai, C. Draunet-Busson, G. Leftheriotis, C. Heymes, M. C. Martinez, and R. Andriantsitohaina Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic Syndrome Am. J. Pathol., October 1, 2008; 173(4): 1210 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jayachandran, R. D. Litwiller, W. G. Owen, J. A. Heit, T. Behrenbeck, S. L. Mulvagh, P. A. Araoz, M. J. Budoff, S. M. Harman, and V. M. Miller Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H931 - H938. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Stampfuss, P. Censarek, D. Bein, K. Schror, M. Grandoch, C. Naber, and A.-A. Weber Membrane environment rather than tissue factor expression determines thrombin formation triggered by monocytic cells undergoing apoptosis J. Leukoc. Biol., June 1, 2008; 83(6): 1379 - 1381. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |